Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Wednesday, June 12, 2024 | Back issues
Courthouse News Service Courthouse News Service

Prescription Drug

GlaxoSmithKline’s skin-rash warning for Lamictal is insufficient, a blinded woman claims in Clark County Court, saying the drug gave her toxic epidermal necrosis, blistering and peeling more than 80 percent of her skin.

LAS VEGAS — GlaxoSmithKline’s skin-rash warning for Lamictal is insufficient, a blinded woman claims in Clark County Court, saying the drug gave her toxic epidermal necrosis, blistering and peeling more than 80 percent of her skin.

Categories / Health, Personal Injury

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...